Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today
10:29am, Thursday, 18'th Nov 2021
Dicerna Pharmaceuticals (DRNA) stock is surging higher on Thursday following news of a massive $3.3 billion deal with Novo Nordisk. The post DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Phar
Novo Nordisk Swallows Dicerna In $3.3B Buyout: All You Need To Know
09:28am, Thursday, 18'th Nov 2021
Novo Nordisk A/S (NYSE: NVO) has agreed to acquire Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) for $38.25 per share in cash, representing a total equity value of $3.3 billion and a premium of 80% t
Why Novo Nordisk (NVO) Is Buying Dicerna Pharmaceuticals (DRNA) For $3.3 Billion
08:54am, Thursday, 18'th Nov 2021
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) announced it entered into a definitive agreement with Novo Nordisk A/S (NYSE: NVO) under which Novo Nordisk will acquire Dicerna. This is why.
Novo Nordisk strikes $3.3 billion to buy research partner Dicerna Pharmaceuticals
07:17am, Thursday, 18'th Nov 2021
Novo Nordisk NVO, +0.37% NOVO.B, +0.69% said it's buying Dicerna Pharmaceuticals DRNA, -0.09% for $3.3 billion, or $38.25 per share in cash. Dicerna ended Wednesday at $21.28.
Deutsche Bank Supplies $211M Refinance Loan on NJ Office Asset
06:46pm, Wednesday, 17'th Nov 2021 Commercial Observer
Hana Financial Group has landed a $210.7 million debt package to refinance Novo Nordisks North American headquarters in New Jersey.
3 Big Pharma Outperformers to Watch Out For in the Near Term
11:28am, Wednesday, 17'th Nov 2021
Eli Lilly (LLY), Pfizer (PFE) and Novo Nordisk (NVO) are three large drugmakers that have outperformed the industry and are good stocks to hold for the next few months and beyond.
Smart Insulin Pens Market Overview and Scope 2021 to 2029 | Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Companion Medical
04:03am, Tuesday, 16'th Nov 2021 OpenPR
Smart Insulin Pens Market The smart insulin pens market was valued at USD 73.8 million in 2019 and is expected to grow with a CAGR of 10.8%. Smart insulin pens are smart devices that are used externally to inject insulin to patients with
